[1] 刘黎黎, 周丛乐, 侯新琳. 新生儿难治性惊厥的研究进展[J]. 中国当代儿科杂志, 2011, 13(1): 77-81.
[2] Bassan H, Ental Y, Shany E, et al. Neonatal seizures: dilemmas in workup and management[J]. Pediatr Neurol, 2008, 38(6): 415-421.
[3] Garcias Da Silva LF, Nunes ML, Da Costa JC. Risk factors for developing epilepsy after neonatal seizures[J]. Pediatr Neurol, 2004, 30(4): 271-277.
[4] Ramos LJ, Aguilera LP, Aguirre R, et al. Early prediction of refractory epilepsy in childhood[J]. Seizure, 2009, 18(6): 412-416.
[5] Milh M, Villeneuve N, Chouchane M, et al. Epileptic and nonepileptic features in patients with early onset epileptic encephalopathy and STXBP1 mutations[J]. Epilepsia, 2011, 52(10): 1828-1834.
[6] Saitsu H, Kato M, Okada I, et al. STXBP1 mutations in early infantile epileptic encephalopathy with suppression-burst pattern[J]. Epilepsia, 2010, 51(12): 2397-2405.
[7] Rizo J, Rosenmund C. Synaptic vesicle fusion [J]. Nat Struct Mol Biol, 2008, 15(7): 665-674.
[8] Wojcik SM, Brose N. Regulation of membrane fusion in synaptic excitation-secretion coupling: speed and accuracy matter[J]. Neuron, 2007, 55(1): 11-24.
[9] Burkhardt P, Hattendorf DA, Weis WI, et al. Munc18a controls SNARE assembly through its interaction with the syntaxin N-peptide[J]. Embo J, 2008, 27(7): 923-933.
[10] Saitsu H, Kato M, Mizuguchi T, et al. De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy[J]. Nat Genet, 2008, 40(6): 782-788.
[11] Shen J, Tareste DC, Paumet F, et al. Selective activation of cognate SNAREpins by Sec1/Munc18 proteins[J]. Cell, 2007, 128(1): 183-195.
[12] Deprez L, Weckhuysen S, Holmgren P, et al. Clinical spectrum of early-onset epileptic encephalopathies associated with STXBP1 mutations[J]. Neurology, 2010, 75(13): 1159-1165.
[13] Hamdan FF, Piton A, Gauthier J, et al. De novo STXBP1 mutations in mental retardation and nonsyndromic epilepsy[J]. Ann Neurol, 2009, 65(6): 748-753.
[14] Otsuka M, Oguni H, Liang JS, et al. STXBP1 mutations cause not only Ohtahara syndrome but also West syndrome-result of Japanese cohort study[J]. Epilepsia, 2010, 51(12): 2449-2452.
[15] Mignot C, Moutard ML, Trouillard O, et al. STXBP1-related encephalopathy presenting as infantile spasms and generalized tremor in three patients[J]. Epilepsia, 2011, 52(10): 1820-1827.
[16] Chelly J, Khelfaoui M, Francis F, et al. Genetics and pathophysiology of mental retardation[J]. Eur J Hum Genet, 2006, 14(6): 701-713.
[17] Zoghbi HY. Postnatal neurodevelopmental disorders: meeting at the synapse?[J]. Science, 2003, 302(5646): 826-830.
[18] Hamdan FF, Gauthier J, Dobrzeniecka S, et al. Intellectual disability without epilepsy associated with STXBP1 disruption[J]. Eur J Hum Genet, 2011, 19(5): 607-609.
[19] Archer HL, Evans J, Edwards S, et al. CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients [J]. J Med Genet, 2006, 43(9): 729-734.
[20] Weaving LS, Christodoulou J, Williamson SL, et al. Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation [J]. Am J Hum Genet, 2004, 75(6): 1079-1093.
[21] Tao J, Van Esch H, Hagedorn-Greiwe M, et al. Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation[J]. Am J Hum Genet, 2004, 75(6): 1149-1154.
[22] Scala E, Ariani F, Mari F, et al. CDKL5/STK9 is mutated in Rett syndrome variant with infantile spasms[J]. J Med Genet, 2005, 42(2): 103-107.
[23] Rosas-Vargas H, Bahi-Buisson N, Philippe C, et al. Impairment of CDKL5 nuclear localization as a cause for severe infantile encephalopathy [J]. J Med Genet, 2008, 45(3): 172-178.
[24] Pavone P, Spalice A, Polizzi A, et al. Ohtahara syndrome with emphasis on recent genetic discovery [J]. Brain Devel, 2012, 34(6): 459-468.
[25] Kato M, Saitoh S, Kamei A, et al. A longer polyalanine expansion mutation in the ARX gene causes early infantile epileptic encephalopathy with suppression-burst pattern (Ohtahara syndrome)[J]. Am J Hum Genet, 2007, 81(2): 361-366.
[26] Kato M, Das S, Petras K, et al. Polyalanine expansion of ARX associated with cryptogenic West syndrome[J]. Neurology, 2003, 61(2): 267-276.